{
    "nctId": "NCT01649661",
    "briefTitle": "MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk",
    "officialTitle": "Epidemiology of MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer Free Women",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 437,
    "primaryOutcomeMeasure": "breast cancer risk factors and background parenchymal enhancement (BPE).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* age 21 years or older\n* be a cancer-free pre- or postmenopausal woman\n* have no prior personal history of any cancer (including DCIS, excluding nonmelanoma skin-cancer)\n* able to speak and read English because the questionnaire is only available in English\n* able to provide informed consent\n\nExclusion Criteria:\n\n* are pregnant at the time of MRI\n* have a prior personal history of any cancer (including DCIS, excluding nonmelanoma skin cancer)",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}